Pharmacies across the United States are weighing whether to sell mifepristone, a pill used in medication abortions, following the Food and Drug Administration's announcement earlier this week that they can now do so.
A spokesperson for GenBioPro, one of two companies that make mifepristone in the United States, said the drugmaker has already started to receive applications for certification but did not provide further details.
"We're in a very small rural area. We're not near an abortion clinic or in a larger city where that happens more," she said. "That's just not something we see here." With the legal issue unsettled, pharmacies in states restricting abortion are likely to face legal risks and could lose their licenses if they decide to sell mifepristone in violation of state laws, said American Pharmacist Association interim CEO Ilisa Bernstein, who worked at the FDA for 30 years.Steve Moore, pharmacist and owner of Condo Pharmacy in Plattsburgh, New York, a state where abortion is legal, plans to dispense the drug.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
2 years on: The aftermath of the January 6 United States Capitol riotsThe January 6 riots at the US Capitol building left five people dead. 2 years later, how is the US dealing with its aftermath?
Baca lebih lajut »
Spring heat waves drive record western United States snow melt in 2021 - IOPscience
Baca lebih lajut »
US Reopening Some Diplomatic Services in Cuba as Immigration From Cuba IncreasesThe United States Embassy in Cuba is reopening visa and consular services Wednesday.
Baca lebih lajut »
2023 Dodge Hornet Flaunts Its Italian Heritage In Turin | CarscoopsThe 2023 Dodge Hornet will be offered with two powertrain options in the United States
Baca lebih lajut »
New fast-spreading COVID variant XBB.1.5 arrives in Houston as experts warn of waning immunityA new omicron COVID-19 variant is spreading fast across the United States and beginning...
Baca lebih lajut »